Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04612036 · ClinicalTrials.gov registry record
In Vivo Kinematics for Subjects With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA
A clinical trial, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- 60
- Enrollment target
NCT04612036 is a clinical trial that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 60 participants.
The verdict
NCT04612036 has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
Interventions
- DEVICE Journey II Bi-Cruciate Stabilized TKA
- DEVICE Journey II Cruciate Retaining TKA
- DEVICE Journey II Bi-Cruciate Retaining TKA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-10-22 |
| Est. Completion | 2022-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04612036
The ClinicalTrials.gov registry entry for NCT04612036 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Tennessee, Knoxville, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Journey II Bi-Cruciate Stabilized TKA is the first listed.
NCT04612036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04612036 about?
NCT04612036 is a clinical study titled "In Vivo Kinematics for Subjects With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA". The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
What is the current status of trial NCT04612036?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-10-22. Estimated completion is 2022-05-16.
What interventions are being tested in trial NCT04612036?
The interventions under investigation include: Journey II Bi-Cruciate Stabilized TKA (DEVICE), Journey II Cruciate Retaining TKA (DEVICE), Journey II Bi-Cruciate Retaining TKA (DEVICE).
Who is sponsoring clinical trial NCT04612036?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.